Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Melki Boutheina (Tunis, Tunisia), Boutheina Melki, Samira Aouadi, Houda Gahrsalli, Dorra Bejar, Soumaya Laabidi, Sonia Maâlej, Leila Douik el Gharbi. Survival in lung cancer: Associated factors in Tunisian patients. Eur Respir J 2015; 46: Suppl. 59, 4310

Member's Comments

No comment yet.

Related content which might interest you: Prognostic factors for survival in lung cancer Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Lung cancer in women: What are particularities? Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer Year: 2014 Predictors of lung cancer patients delay time in Serbia - a cross-sectional study Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Lung cancer in patients before the age of 45: A retrospective analysis of 62 patients Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features Year: 2015 Lung cancer after lymphoma: Disease characteristics, detection methods and clinical outcome Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013 Lung cancer, has it changed in the last ten years? Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Diagnosing lung cancer: Choosing the best for your patient Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Surgical treatment outcomes on early-stages of non-small-cell lung cancer Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Improving survival for NSCLC patients in the national lung cancer audit Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Maintenance therapy with pemetrexed in non-small-cell lung cancer: Impact on survival Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015 Chemotherapy beyond 3rd line in NSCLC – A retrospective analysis Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015 Comorbitities, responses and survival in pts with NSCLC Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Safety and efficacy of erlotinib in patients with squamous cell lung cancer Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Lung cancer in women: Is it different? Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Physiological predictors of mortality in high-risk patients undergoing surgery for lung cancer Source: International Congress 2016 – Clinical aspects of lung cancer Year: 2016 ALK/EML4 translocation in non-squamous NSCLC and their predictors Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Assessment of nutritional status in patients with primary lung cancer Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Locally advanced stage nonsmallcell cancers explode in hyperglisemia: A new prognostic factors? Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Chemotherapy in elderly patients with non-small-cell lung cancer in Tunisian respiratory department Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013 Characteristics of smoking behaviour in patients post-curative resection of stage 1 lung cancer Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015